If you have a pancreatitis history and are considering GLP-1 therapy, the Precision Peptide Genetic Test can support a more personalized conversation with your provider by clarifying your genetic metabolic profile alongside your clinical risk factors
This was described by the original authors as "very surprising" and represented a categorically different selectivity profile from all previously characterised GHRP receptor agonists
Weight Loss: While weight loss can be a desirable outcome for many individuals with type 2 diabetes, excessive weight loss associated with GLP-1 medications may be problematic for some patients, especially those who are already at a healthy weight or at risk of malnutrition
In small ruminants, pregnancy is a complex process that involves numerous physiological changes in pregnancy-related tissues (Kandil et al., 2025
Improper storage could lead to vitamin degradation (losing potency) or increased risk of injection site reactions (if contaminants or precipitates form), so patients and providers should take the storage guidelines seriously